JPS62298761A - Fluorescent immunoassay - Google Patents

Fluorescent immunoassay

Info

Publication number
JPS62298761A
JPS62298761A JP14130786A JP14130786A JPS62298761A JP S62298761 A JPS62298761 A JP S62298761A JP 14130786 A JP14130786 A JP 14130786A JP 14130786 A JP14130786 A JP 14130786A JP S62298761 A JPS62298761 A JP S62298761A
Authority
JP
Japan
Prior art keywords
antibody
bonding
labelled
antibodies
beads
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14130786A
Other languages
Japanese (ja)
Inventor
Kenji Yasuda
健二 保田
Daizo Tokinaga
時永 大三
Teruaki Kobayashi
映章 小林
Kazunari Imai
一成 今井
Satoshi Takahashi
智 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
Agency of Industrial Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency of Industrial Science and Technology filed Critical Agency of Industrial Science and Technology
Priority to JP14130786A priority Critical patent/JPS62298761A/en
Publication of JPS62298761A publication Critical patent/JPS62298761A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To measure a plurality of antigens in the same sample at a high sensitivity simultaneously, by using a labelled antibody produced by bonding an antibody to a phycobiliprotein as fluorochrome protein. CONSTITUTION:The bonding of an antibody to a phycobiliprotein is executed by an ordinary method. A bonding is performed between R-phycoerythrin and an anti-human albumin antibody, C-phycocyanine and an anti-human immunoglobulin G antibody, allophycocyanine and an anti-humam immunoglobulin A antibody. On the other hand, three kind of antibodies not labelled are immobilized on respective carboxylated polyacryl amide gel beads. These three kind of bead suspensions are taken into equivalent test tubes and a mixed reference liquid of an antibody to be inspected is added to each of the test tubes and the supernatant is thrown away after a reaction. Liquids of antibodies labelled of said three kinds are added to the beads to react, after a washing and separation are conducted, the beads are suspended in a buffer. The intensity of fluorescence is measured using excitation wavelength and emission wavelength suitable for individual phycobiliproteins.

Description

【発明の詳細な説明】 3、発明の詳細な説明 〔産業上の利用分野〕 本発明はイムノアッセイ法に係り、特に生体試料中の微
量成分の検出に好適なイムノアッセイ法に関する。
Detailed Description of the Invention 3. Detailed Description of the Invention [Field of Industrial Application] The present invention relates to an immunoassay method, and particularly to an immunoassay method suitable for detecting trace components in biological samples.

〔従来の技術〕[Conventional technology]

従来、フィコビリ蛋白質を用いたイムノアッセイ法とし
ては、クリニカル・ケミストリー、第29巻(1983
年)第1582頁から第1586頁(CIin、 Ch
ew、、 29 、  (1983)Pρ、1582−
1586)においてフィコエリトリンを用いたイムノア
ッセイ法が論じられているが、一種類の蛋白質を用いた
ものであり、複数種のフィコビリ蛋白質を異なる抗体に
結合させてアッセイに用いた例は知られていない。
Conventionally, immunoassay methods using phycobiliproteins have been described in Clinical Chemistry, Vol. 29 (1983).
) pages 1582 to 1586 (CIin, Ch.
ew,, 29, (1983) Pρ, 1582-
1586) discusses an immunoassay method using phycoerythrin, but it uses one type of protein, and there is no known example of using multiple types of phycobiliproteins in an assay by binding them to different antibodies.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

上記従来技術は一種類のフィコビリ蛋白質の利用につい
て論じており、複数の測定対象を同一の試料から検出す
るという点については配慮がされていないため、ある疾
患を、またある生体の状態を総合的に判断するのに十分
な情報が迅速に得られなかった。また低分子の有機蛍光
物質を種類を変えて標識する方法も考えられるが、これ
らの標識試薬は一般に、水への溶解性が低く、抗体への
結合が容易でなく、量子収率やモル吸光係数もごく一部
の試薬(フルオレセインやローダミンB)を除けば小さ
いなどの問題のために、複数の抗原を感度良く同時に測
定するのはきわめて難しかった。
The above-mentioned conventional technology discusses the use of one type of phycobiliprotein and does not take into consideration the detection of multiple measurement targets from the same sample. Not enough information could be obtained quickly to make a decision. Another option is to label different types of low-molecular organic fluorescent substances, but these labeling reagents generally have low solubility in water, are difficult to bind to antibodies, and have low quantum yield and molar absorption. Due to problems such as low coefficients except for a few reagents (fluorescein and rhodamine B), it has been extremely difficult to measure multiple antigens simultaneously with high sensitivity.

本発明の目的は、複数の抗原を含む同一の試料から抗原
を高感度に測定することにある。
An object of the present invention is to measure antigens with high sensitivity from the same sample containing multiple antigens.

〔問題点を解決するための手段〕[Means for solving problems]

上記目的を達成するために、蛍光性色素蛋白質であるC
−フィコエリトリン、B−フィコエリトリン、R−フィ
コエリトリン、C−フィコシアニン、R−フィコシアニ
ン、アロフィコシアニンなどから成るフィコビリ蛋白質
を用い、抗体と結合させ、イムノアッセイに適用した。
In order to achieve the above purpose, C
- Phycobili proteins consisting of phycoerythrin, B-phycoerythrin, R-phycoerythrin, C-phycocyanin, R-phycocyanin, allophycocyanin, etc. were used, combined with antibodies, and applied to immunoassays.

ここで抗体とは抗体のFab’成分(活性を有する切断
断片)も含むものとする。抗体とフィコビリ蛋白質の結
合は常法([蛋白質の化学修飾(」二、下)」。
Here, the term "antibody" includes the Fab' component (active cleavage fragment) of the antibody. Binding of antibodies and phycobiliproteins is carried out by a conventional method ([Chemical modification of proteins (2, 2)].

大野、金岡、崎山、前田著、学会出版センター刊198
1年など)に従って、抗体のアミノ基、またはカルボキ
シル基とフィコビリ蛋白質のカルボキシル基またはアミ
ノ基とを架橋試薬で結合させるか、又は抗体のFab’
成分のチオール基とフィコビリ蛋白質のアミノ基とを同
様な方法で結合させる方法で行なうことができる。
Written by Ohno, Kanaoka, Sakiyama, and Maeda, published by Gakkai Publishing Center, 198.
1 year, etc.), the amino group or carboxyl group of the antibody and the carboxyl group or amino group of the phycobiliprotein are bonded with a cross-linking reagent, or the Fab' of the antibody is
This can be carried out by bonding the thiol group of the component and the amino group of the phycobiliprotein in a similar manner.

〔作用〕[Effect]

フィコビリ蛋白質は一群の蛍光性色素蛋白質であり、吸
光波長、蛍光波長とも480nm以上と共存成分の妨害
を受けにくい長波長領域にある。
Phycobiliproteins are a group of fluorescent pigment proteins, and both absorption and fluorescence wavelengths are in the long wavelength region of 480 nm or more, which is less susceptible to interference by coexisting components.

また量子収率も0.51−0.98ときわめて高く、−
T−/L/吸光係数も2.3−24.IX]05M  
”cm  ’と非常に大きい。低分子蛍光物質フルオレ
セイン(モル吸光係数9 X 10 ’ M  ’ c
m  ’ 。
In addition, the quantum yield is extremely high at 0.51-0.98, -
T-/L/extinction coefficient is also 2.3-24. IX]05M
Very large at ``cm''.Low molecular fluorescent substance fluorescein (molar extinction coefficient 9 x 10'M'c
m'.

量子収率0.65)の数倍から数十倍の蛍光強度が得ら
れる。主なフィコビリ蛋白質としてはB−とb−とR−
フィコエリトリン、C−とR−フィコシアニン、アロフ
ィコシアニンがある。蛋白質なので水溶性であり、抗体
と結合させるための官能基も容易に利用できる。
A fluorescence intensity several to several tens of times higher than the quantum yield (0.65) can be obtained. The main phycobiliproteins are B-, b-, and R-
These include phycoerythrin, C- and R-phycocyanin, and allophycocyanin. Since it is a protein, it is water-soluble, and functional groups for binding to antibodies are easily available.

〔実施例〕〔Example〕

以下、本発明の実施例を述べる。 Examples of the present invention will be described below.

実施例I R−フィコエリトリンと抗ヒトアルブミン抗体とに、と
もにN−スクシンイミジル−3−(2−ピリジルジチオ
)プロピオン酸でチオール基を導入する(クリニカル・
ケミストリー(CHn。
Example I A thiol group is introduced into R-phycoerythrin and an anti-human albumin antibody using N-succinimidyl-3-(2-pyridyldithio)propionic acid (clinical method).
Chemistry (CHn.

Chem、)29.1582 (1983)参照)。チ
オール化した抗体とR−フィコエリトリンを混合し、S
H,−8−8−交換反応により両者を結合させる。過剰
のチオール基はN−エチルマレイミドで不活性にする。
Chem, ) 29.1582 (1983)). Mix thiolated antibody and R-phycoerythrin,
Both are combined by H, -8-8- exchange reaction. Excess thiol groups are rendered inactive with N-ethylmaleimide.

一方、C−フィコシアニンと抗ヒト免疫グロブリンG抗
体とに同様にしてチオール基を導入し、上記のようにC
−フィコシアニン標識抗体を調製する。さらにアロフィ
コシアニンを抗ヒト免疫グロブリンAに同様にして結合
させる。
On the other hand, thiol groups were introduced into C-phycocyanin and anti-human immunoglobulin G antibody in the same manner, and C-phycocyanin and anti-human immunoglobulin G antibodies were introduced in the same manner.
- Prepare phycocyanin-labeled antibodies. Furthermore, allophycocyanin is bound to anti-human immunoglobulin A in the same manner.

以上3種のフィコビリ蛋白質標識抗体を使用して、ヒト
血清中のアルブミン、免疫グロブリンG。
Albumin and immunoglobulin G in human serum were detected using the above three types of phycobiliprotein-labeled antibodies.

免疫グロブリンAを測定した。まず3種の混合標準溶液
(アル1足25 ブリン0 3 g / 1 0 0 m Q 、免疫グ
ロブリンAO.5g/loomQを含む生理的食塩水)
を希釈しておく。一方標識していない抗体3種類をそれ
ぞれカルボキシル化ポリアクリルアミドゲルのビーズ(
直径3μmから10μm)に固定化しておいた。この3
種のビーズ懸濁液を等量試験管に取り、これに混合標準
溶液を加え、約1時間37℃で反応させ、遠心分離し、
上澄みを捨てた。次に前記3種類の標識抗体液を加え、
約1時間37℃で反応させた。これに洗浄用緩衝液(P
H7.4。
Immunoglobulin A was measured. First, three mixed standard solutions (physiological saline containing AO.5g/roomQ, immunoglobulin AO.5g/roomQ)
Dilute it. On the other hand, three types of unlabeled antibodies were each placed on carboxylated polyacrylamide gel beads (
(diameter 3 μm to 10 μm). This 3
Take an equal amount of the seed bead suspension into a test tube, add the mixed standard solution to it, react at 37°C for about 1 hour, centrifuge,
The supernatant was discarded. Next, add the three types of labeled antibody solutions,
The reaction was carried out at 37°C for about 1 hour. Add washing buffer (P
H7.4.

0、01Mリン酸ナトリウム緩衝液、0.15Mの塩化
ナトリウムを含む)を加え、よくかくはんしたのち、遠
心分離し、上澄みを捨てる。沈殿したポリアクリルアミ
ド・ビーズを測定用緩衝液(pH7.4,0.05Mリ
ン酸緩衝液)に懸濁し、直ちに、蛍光測定セルに移し、
蛍光強度を測定した。R−フィコエリトリンは励起波長
480nm。
After stirring well, centrifuge and discard the supernatant. The precipitated polyacrylamide beads were suspended in a measurement buffer (pH 7.4, 0.05M phosphate buffer) and immediately transferred to a fluorescence measurement cell.
Fluorescence intensity was measured. R-phycoerythrin has an excitation wavelength of 480 nm.

発光波長580nm,C−フィコシアニンは励起波長6
20nm,発光波長650nm,アロフィコシアニンは
励起波長650nm,発光波長665nmで順次測定し
た。この測定操作による検量線を第1図に示す。各測定
対象ともほぼ良好な検量線が得られた。本検量線を用い
てヒト血清20検体について上記の操作によりアッセイ
を行った結果を、比ろう法(ネフェロメータ)による測
定値を比較したところ、相関係数0.97〜0、98と
良好な一致が見られた。
Emission wavelength 580 nm, C-phycocyanin excitation wavelength 6
Allophycocyanin was measured sequentially at an excitation wavelength of 650 nm and an emission wavelength of 665 nm. A calibration curve obtained by this measurement procedure is shown in FIG. Approximately good calibration curves were obtained for each measurement target. The results of assaying 20 human serum samples according to the above procedure using this standard curve were compared with the measured values using a nephelometer, and the correlation coefficient was 0.97 to 0.98, indicating good agreement. It was observed.

実施例2 ポリスチレン試験管に測定対象に対する抗体を固定して
おく。本実施例では抗ヒトα−フェトプロティン抗体と
抗フェリチン抗体とを吸着させておいた。この試験管に
抗原を含む試料を入れ、抗体と約2時間反応させた。次
にいったん試験管を洗浄用緩衝液で洗浄したのち、C−
フィコシアニンで標識した抗ヒトα−フェトプロティン
抗体とR−フィコエリトリンで標識した抗フェリチン抗
体とをO,1mg/mfl程度含有するリン酸緩衝生理
的食塩水(pH7,4)を加え、37℃で約1時間保っ
た。試験管内の溶液を吸引し、蛍光光度計のフローセル
中に導いて蛍光強度を測定し、その強度の減少度合から
抗原濃度を測定した。両抗原を任意に混合した標準試料
20検体で両者を別々に測定できた。
Example 2 An antibody against a measurement target is immobilized on a polystyrene test tube. In this example, an anti-human α-fetoprotein antibody and an anti-ferritin antibody were adsorbed. A sample containing the antigen was placed in this test tube and reacted with the antibody for about 2 hours. Next, after washing the test tube with washing buffer,
Phosphate buffered saline (pH 7.4) containing about 1 mg/mfl of anti-human α-fetoprotein antibody labeled with phycocyanin and anti-ferritin antibody labeled with R-phycoerythrin was added, and the mixture was heated at 37°C to approx. I kept it for an hour. The solution in the test tube was aspirated and introduced into a flow cell of a fluorometer to measure the fluorescence intensity, and the antigen concentration was determined from the degree of decrease in the intensity. Both antigens could be measured separately using 20 standard samples in which both antigens were mixed arbitrarily.

〔発明の効果〕〔Effect of the invention〕

本発明は、高感度多項目分析という目的に対して蛍光強
度が強く、異なる励起・発光スペクトルを有する複数の
フィコビリ蛋白質を利用することにより、同一の試料か
ら複数の抗原を感度良く測定できる。
The present invention makes it possible to measure multiple antigens from the same sample with high sensitivity by utilizing multiple phycobiliproteins with strong fluorescence intensity and different excitation and emission spectra for the purpose of highly sensitive multi-item analysis.

また同一の試料で複数の抗原を測定できることから総測
定時間の短縮、試料量の減少という効果が得られる。
Furthermore, since multiple antigens can be measured in the same sample, the total measurement time can be shortened and the amount of sample can be reduced.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明の実施例1で使用した検量線を示す図で
ある。
FIG. 1 is a diagram showing a calibration curve used in Example 1 of the present invention.

Claims (1)

【特許請求の範囲】[Claims] 1、蛍光発光波長の異なるフィコビリ蛋白質を結合させ
た抗体を被測定抗原ごとに調製する工程と、上記抗体を
複数の被測定抗原を含む試料と反応させる工程とよりな
ることを特徴とする蛍光イムノアッセイ法。
1. A fluorescence immunoassay characterized by comprising the steps of preparing an antibody bound to phycobiliproteins having different fluorescence emission wavelengths for each antigen to be measured, and reacting the antibody with a sample containing a plurality of antigens to be measured. Law.
JP14130786A 1986-06-19 1986-06-19 Fluorescent immunoassay Pending JPS62298761A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14130786A JPS62298761A (en) 1986-06-19 1986-06-19 Fluorescent immunoassay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14130786A JPS62298761A (en) 1986-06-19 1986-06-19 Fluorescent immunoassay

Publications (1)

Publication Number Publication Date
JPS62298761A true JPS62298761A (en) 1987-12-25

Family

ID=15288846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14130786A Pending JPS62298761A (en) 1986-06-19 1986-06-19 Fluorescent immunoassay

Country Status (1)

Country Link
JP (1) JPS62298761A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58140641A (en) * 1982-02-17 1983-08-20 Hitachi Ltd Quantitative determination method of immunity
JPS58160866A (en) * 1981-10-06 1983-09-24 ザ・ボ−ド・オブ・トラステイ−ズ・オブ・ザ・リ−ランド・スタンフオ−ド・ジユニア・ユニバ−シテイ Fluorescent compound

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58160866A (en) * 1981-10-06 1983-09-24 ザ・ボ−ド・オブ・トラステイ−ズ・オブ・ザ・リ−ランド・スタンフオ−ド・ジユニア・ユニバ−シテイ Fluorescent compound
JPS58140641A (en) * 1982-02-17 1983-08-20 Hitachi Ltd Quantitative determination method of immunity

Similar Documents

Publication Publication Date Title
US4133639A (en) Test article including a covalently attached diagnostic reagent and method
KR100804202B1 (en) Chromatographic assay system
US6376187B1 (en) Electronically-indexed solid-phase assay for biomolecules
JP2002303629A (en) Immune chromatography device and method for determining substance to be tested using the same
JPH03502244A (en) Test method and reagent kit
US6551788B1 (en) Particle-based ligand assay with extended dynamic range
JP2008304401A (en) Label silica nano-particle for immuno-chromatography reagent, immuno-chromatography reagent, test strip for immuno-chromatography using it, and fluorescence detecting system for immuno-chromatography
JP2007519933A (en) Systems, methods, and reagents for detection of biological and chemical materials using dynamic surface generation and imaging
JP2009115822A (en) Label silica nano-particle for immuno-chromatography reagent, immuno-chromatography reagent, test strip for immuno-chromatography using it, and fluorescence detection system for immuno-chromatography
CN113156119A (en) Method for detecting coronavirus by adopting angiotensin converting enzyme II (ACE2)
WO2017206800A1 (en) Centrifugal chromatography immunoassay method
CN111381025A (en) Immunoassay kit for multiplex detection, application and multiplex detection method
JP5006459B1 (en) Composite particles for labeling
US20200333337A1 (en) Method for re-using test probe and reagents in an immunoassay
US20210164974A1 (en) Chromatographic strip comprising multiple test lines, diagnostic kit comprising same, and qualitative, semi-quantitative or quantitative analysis method comprising multiple competitive reaction measurement steps
WO2019088142A1 (en) Detection agent for bioassay and signal amplification method using same
US20230305001A1 (en) Ultra-sensitive digital rapid chromatographic assay system and method for analytes detection
US20160341723A1 (en) Au nanoparticles encapsulated in nanocompoites and applications thereof in rapid detection of an analyte
KR101548284B1 (en) A Novel Method for Detecting an Analyte and Kits Using It
EP0201211A1 (en) Method and compositions for visual solid phase immunoassays based on luminescent microspheric particles
CN100414296C (en) Embedded high-pass three-dimensional biological detecting technique and agent box
JPH03272466A (en) Multiple immunologocal evaluating analyzing system
JPS62298761A (en) Fluorescent immunoassay
JPS6281566A (en) Quantification method by measurement of fluorescent intensity of fine particle
CN112782404B (en) Multiplex biomarker detection kit based on fluorescence immunoassay method